ÇİFTÇİ, E. Et Al. 2017. Diagnostic importance of F-18-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions. NUCLEAR MEDICINE COMMUNICATIONS , vol.38, no.9 , 788-794.

ÇİFTÇİ, E., TURGUT, B., ÇAKMAKCILAR, A., & ERTÜRK, S. A., (2017). Diagnostic importance of F-18-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions. NUCLEAR MEDICINE COMMUNICATIONS , vol.38, no.9, 788-794.

ÇİFTÇİ, ESRA Et Al. "Diagnostic importance of F-18-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions," NUCLEAR MEDICINE COMMUNICATIONS , vol.38, no.9, 788-794, 2017

ÇİFTÇİ, ESRA Et Al. "Diagnostic importance of F-18-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions." NUCLEAR MEDICINE COMMUNICATIONS , vol.38, no.9, pp.788-794, 2017

ÇİFTÇİ, E. Et Al. (2017) . "Diagnostic importance of F-18-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions." NUCLEAR MEDICINE COMMUNICATIONS , vol.38, no.9, pp.788-794.

@article{article, author={ESRA ÇİFTÇİ Et Al. }, title={Diagnostic importance of F-18-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions}, journal={NUCLEAR MEDICINE COMMUNICATIONS}, year=2017, pages={788-794} }